Validation of a gene expression-based subclassification strategy for pediatric septic shock

Critical Care Medicine

Volumn 39, Issue 11, 2011, Pages 2511-2517

  Wong, Hector R ^a   Cvijanovich, Natalie Z ^b   Allen, Geoffrey L ^c   Thomas, Neal J ^d   Freishtat, Robert J ^e   Anas, Nick ^f   Meyer, Keith ^g   Checchia, Paul A ^h   Lin, Richard ⁱ   Shanley, Thomas P ^j   Bigham, Michael T ^k   Wheeler, Derek S ^a   Doughty, Lesley A ^a   Tegtmeyer, Ken ^a   Poynter, Sue E ^a   Kaplan, Jennifer M ^a   Chima, Ranjit S ^a   Stalets, Erika ^a   Basu, Rajit K ^a   Varisco, Brian M ^a   Barr, Frederick E ^a   more..

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OAKLAND   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d PENN STATE CHILDREN S HOSPITAL   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

^g MIAMI CHILDREN'S HOSPITAL   (United States)

^h ST LOUIS CHILDREN S HOSPITAL   (United States)

ⁱ CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^j UNIVERSITY OF MICHIGAN   (United States)

^k AKRON CHILDREN'S HOSPITAL   (United States)

more..

Author keywords

gene expression; microarray; pediatrics; septic shock; staging; stratification

Indexed keywords

GLUCOCORTICOID RECEPTOR;

ADAPTIVE IMMUNITY; ARTICLE; CHILD; FEMALE; GENE EXPRESSION; HUMAN; INFANT; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SEPTIC SHOCK;

EID: 80054882327     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3182257675     Document Type: Article

References (38)

1. Wynn J, Cornell TT, Wong HR, et al: The host response to sepsis and developmental impact. Pediatrics 2010; 125:1031-1041
2. Hotchkiss RS, Karl IE: The pathophysiology and treatment of sepsis. N Engl J Med 2003; 348:138-150 (Pubitemid 36056721)
3. Marshall JC: Sepsis: Rethinking the approach to clinical research. J Leukoc Biol 2008; 83: 471-482 (Pubitemid 351966853)
4. Marshall JC, Reinhart K: Biomarkers of sepsis. Crit Care Med 2009; 37:2290-2298
5. Wong HR: Pediatric septic shock treatment: New clues from genomic profiling. Pharmacogenomics 2007; 8:1287-1290 (Pubitemid 350162844)
6. Wong HR, Cvijanovich N, Lin R, et al: Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 2009; 7:34
7. Wong HR, Wheeler DS, Tegtmeyer K, et al: Toward a clinically feasible gene expressionbased subclassification strategy for septic shock: Proof of concept. Crit Care Med 2010; 38:1955-1961
8. Goldstein B, Giroir B, Randolph A: International pediatric sepsis consensus conference: Definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med 2005; 6:2-8
9. Wong HR, Cvijanovich N, Allen GL, et al: Genomic expression profiling across the pediatric systemic inflammatory response syndrome, sepsis, and septic shock spectrum. Crit Care Med 2009; 37:1558-1566
10. Wong HR, Shanley TP, Sakthivel B, et al: Genome level expression profiles in pediatric septic shock indicate a role for altered zinc homeostasis in poor outcome. Physiol Genomics 2007; 30:146-155 (Pubitemid 47173278)
11. Pollack MM, Patel KM, Ruttimann UE: The Pediatric Risk of Mortality III-Acute Physiology Score (PRISM III-APS): A method of assessing physiologic instability for pediatric intensive care unit patients. J Pediatr 1997; 131:575-581 (Pubitemid 28006932)
12. Shanley TP, Cvijanovich N, Lin R, et al: Genome-level longitudinal expression of signaling pathways and gene networks in pediatric septic shock. Mol Med 2007; 13:495-508 (Pubitemid 47585744)
13. Cvijanovich N, Shanley TP, Lin R, et al: Validating the genomic signature of pediatric septic shock. Physiol Genomics 2008; 34: 127-134
14. Wong HR, Freishtat RJ, Monaco M, et al: Leukocyte subset-derived genome-wide expression profiles in pediatric septic shock. Pediatr Crit Care Med 2010; 11:349-355
15. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003; 4:249-264
16. Eichler GS, Huang S, Ingber DE: Gene Expression Dynamics Inspector (GEDI): For integrative analysis of expression profiles. Bioinformatics 2003; 19:2321-2322 (Pubitemid 37483992)
17. Guo Y, Eichler GS, Feng Y, et al: Towards a holistic, yet gene-centered analysis of gene expression profiles: A case study of human lung cancers. J Biomed Biotechnol 2006; 2006:69141
18. Sun L, Gorospe JR, Hoffman EP, et al: Decreased platelet expression of myosin regulatory light chain polypeptide (MYL9) and other genes with platelet dysfunction and CBFA2/RUNX1 mutation: Insights from platelet expression profiling. J Thromb Haemost 2007; 5:146-154 (Pubitemid 44921080)
19. Tang BM, Huang SJ, McLean AS: Genomewide transcription profiling of human sepsis: A systematic review. Crit Care 2010; 14:R237
20. Baue AE, Durham R, Faist E: Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle? Shock 1998; 10:79-89 (Pubitemid 128463838)
21. Barie PS, Hydo LJ: Influence of multiple organ dysfunction syndrome on duration of critical illness and hospitalization. Arch Surg 1996; 131:1318-1323, discussion 1324
22. Typpo KV, Petersen NJ, Hallman DM, et al: Day 1 multiple organ dysfunction syndrome is associated with poor functional outcome and mortality in the pediatric intensive care unit. Pediatr Crit Care Med 2009; 10: 562-570
23. Vincent JL, Opal SM, Marshall JC: Ten reasons why we should NOT use severity scores as entry criteria for clinical trials or in our treatment decisions. Crit Care Med 2010; 38: 283-287
24. Czaja AS, Zimmerman JJ, Nathens AB: Readmission and late mortality after pediatric severe sepsis. Pediatrics 2009; 123:849-857
25. Watson RS, Carcillo JA, Linde-Zwirble WT, et al: The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med 2003; 167:695-701 (Pubitemid 36801744)
26. Watson RS, Carcillo JA: Scope and epidemiology of pediatric sepsis. Pediatr Crit Care Med 2005; 6(Suppl):S3-S5 (Pubitemid 40724243)
27. Calvano SE, Xiao W, Richards DR, et al: A network-based analysis of systemic inflammation in humans. Nature 2005; 437: 1032-1037 (Pubitemid 41486985)
28. Hotchkiss RS, Opal S: Immunotherapy for sepsis-A new approach against an ancient foe. N Engl J Med 2010; 363:87-89
29. Levy Y, Lacabaratz C, Weiss L, et al: Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J Clin Invest 2009; 119:997-1007
30. Rosenberg SA, Sportes C, Ahmadzadeh M, et al: IL-7 administration to humans leads to expansion of CD8+ and CD4+ cells but a relative decrease of CD4+ T-regulatory cells. J Immunother 2006; 29:313-319 (Pubitemid 44297299)
31. Sereti I, Dunham RM, Spritzler J, et al: IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection. Blood 2009; 113:6304-6314
32. Sportes C, Hakim FT, Memon SA, et al: Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J Exp Med 2008; 205:1701-1714 (Pubitemid 351962032)
33. Unsinger J, McGlynn M, Kasten KR, et al: IL-7 promotes T cell viability, trafficking, and functionality and improves survival in sepsis. J Immunol 2010; 184:3768-3779
34. Sprung CL, Goodman S, Weiss YG: Steroid therapy of septic shock. Crit Care Clin 2009; 25:825-834, x
35. Annane D, Sebille V, Charpentier C, et al: Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 2002; 288: 862-871
36. Sprung CL, Annane D, Keh D, et al: Hydrocortisone therapy for patients with septic shock. N Engl J Med 2008; 358:111-124
37. Osuchowski MF, Connett J, Welch K, et al: Stratification is the key: Inflammatory biomarkers accurately direct immunomodulatory therapy in experimental sepsis. Crit Care Med 2009; 37:1567-1573
38. Wong HR, Cvijanovich N, Wheeler DS, et al: Interleukin-8 as a stratification tool for interventional trials involving pediatric septic shock. Am J Respir Crit Care Med 2008; 178:276-282